Back to Search Start Over

Supplementary Tables 1-3 from A Phase Ib/II Study of Ramucirumab in Combination with Emibetuzumab in Patients with Advanced Cancer

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....3c0bf9a45880b36e2d6a20836105b167
Full Text :
https://doi.org/10.1158/1078-0432.22472018